Respiratory disease diagnostics ProAxsis secures c.£1.8 million investment
LONDON: NetScientific Plc (AIM: NSCI) announced that its portfolio company ProAxsis Limited has successfully closed a c.£1.8 million investment. The investment was led by the Company’s wholly owned venture capital and corporate finance firm, EMV Capital, syndicated from a cohort…